3.238.176.43
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Autoimmune
Conference Roundup
Pulmonary and Lung

AAAI Cancels Annual Meeting

Posted on March 14, 2020

The American Academy of Allergy, Asthma & Immunology (AAAAI) announced they have decided to cancel the 2020 Annual Meeting scheduled to take place March 13-16 in Philadelphia due to the evolving situation with the coronavirus disease 2019 (COVID-19).

“Cancelling the 2020 AAAAI Annual Meeting was a difficult decision made by the AAAAI Board of Directors after careful thought and deliberation,” said AAAAI President David M. Lang, MD, FAAAAI in the announcement. “While an incredible amount of work went into planning this year’s educational program, and all of our speakers and abstract authors have put immense time and energy into their presentations and posters, it has reached a point with COVID-19 where the AAAAI felt it was absolutely necessary to cancel the Annual Meeting in order to protect the health and safety of attendees.”

Read the full announcement here

-Advertisement-
Related Articles
FDA Grants DSG3-CAART Orphan Drug Designation for the Treatment of Pemphigus Vulgaris
May 31, 2021
Data from Trial Evaluating Eculizumab for the Treatment of Neuromyelitis Optica Spectrum Disorder to be Presented at AAN Annual Meeting
May 31, 2020
Part 1 Results from PIONEER Trial in Indolent Systemic Mastocytosis Announced
Mar 16, 2020
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-